Correction
Published on 24 Aug 2023
Corrigendum: Multifunctions of CRIF1 in cancers and mitochondrial dysfunction
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1271492
- 945 views
Type at least 3 characters
2,927 articles
Articles
Correction
Published on 23 Aug 2023
Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1247057
- 753 views
Original Research
Published on 22 Aug 2023
Dissecting the effects of METTL3 on alternative splicing in prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1227016
- 2,961 views
- 3 citations
Original Research
Published on 22 Aug 2023
Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1151687
- 1,802 views
- 1 citation
Original Research
Published on 21 Aug 2023
Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1212585
- 1,484 views
- 3 citations
Editorial
Published on 21 Aug 2023
Editorial: The tumor microenvironment and malignant properties in primary liver cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1264439
- 959 views
Editorial
Published on 18 Aug 2023
Editorial: Exploring cancer stem cells signaling pathways
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1274509
- 1,320 views
Review
Published on 17 Aug 2023
RETRACTED: New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1193736
- 3,711 views
- 1 citation
Review
Published on 10 Aug 2023
Exploring the regulatory role of lncRNA in cancer immunity
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1191913
- 4,470 views
- 6 citations
Review
Published on 10 Aug 2023
Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1242725
- 1,679 views
- 1 citation
Original Research
Published on 10 Aug 2023
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1127645
- 3,897 views
- 6 citations
Review
Published on 09 Aug 2023
Molecular mechanism of palmitic acid and its derivatives in tumor progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1224125
- 8,076 views
- 23 citations
Review
Published on 03 Aug 2023
Biological functions and research progress of eIF4E
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1076855
- 3,224 views
- 12 citations
Review
Published on 03 Aug 2023
E-box binding transcription factors in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1223208
- 5,121 views
- 11 citations
Mini Review
Published on 28 Jul 2023
Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1233376
- 3,171 views
- 6 citations
Editorial
Published on 24 Jul 2023
Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1226974
- 1,251 views
- 2 citations